Vaccines & Clinical Science Through the Lens of COVID-19

RECORD | Already taken place Th, 24.6.2021
Explore how to apply lessons learned from the global COVID-19 pandemic to pave the way for new approaches to vaccine development, therapeutics and clinical science.
Waters Corporation: Vaccines & Clinical Science Through the Lens of COVID-19
Waters Corporation: Vaccines & Clinical Science Through the Lens of COVID-19

SelectScience and Waters Corporation invite you to join us as we explore how to apply lessons learned from the global COVID-19 pandemic to pave the way for new approaches to vaccine development, therapeutics and clinical science.

We will explore these lessons from the perspective of those who delivered groundbreaking science faster than ever before. There is no turning back…

Why attend?

In this one-day virtual event, we will:
  • Take compelling solutions forward to future vaccine development through case studies
  • Discuss major unsolved problems
  • Explore groundbreaking and innovative technology in therapeutics and clinical science

By attending this event, you will have the opportunity to hear from keynote speakers and experts across the globe, and engage with them via Q&A and networking. You'll also be able to access relevant application and product resources.

Why attend?

Scientists, lab managers and directors interested in and/or working on vaccine and therapeutic development and commercialization.

Agenda – June 24th 2021

14:45 CEST : Welcome Address
  • Presenter: Diane Diehl (Senior Director, Scientific Operations, Waters Corporation)

Analytical Development of Complex Modalities

15:00 CEST : Classical and next-generation vaccine modality characterization by Charge Detection Mass Spectrometry
  • Presenter: Ben Draper (Mega Dalton Solutions)
16:00 CEST : Synthetic mRNA-based vaccines – overview and considerations
  • Presenter: Bijoyita Roy (New England Biolabs Inc)
  • Presenter: Jennifer Nguyen (Waters Corporation)
17:00 CEST : Characterization to Support Identification of Cell Culture CQAs
  • Presenter: Chris Chumsae (Bristol Myers Squibb)

Operational Reponses

15:00 CEST : Title TBC
  • Presenter: Tom Brown (ATD Bio)
16:00 CEST : Implementation of automation technologies within operations
  • Presenter: Jeremy Springall (AstraZeneca)
17:00 CEST : Title TBC
  • Presenter: Dr. Elliot Franco (Alcami)
  • Presenter: Pat Walsh (Alcami)

LC-MS Alternative to PCR

15:00 CEST : COVID-MS – From Research to Ramp up
  • Presenter: Professor Don Jones (University of Leicester)
16:00 CEST : Blood, sweat, swabs and tears
  • Presenter: Rachel Carling (ViaPath)
17:00 CEST : Instrumental sensitivity and enrichment amplify the signal, not the target molecule
  • Presenter: Dr. Maarten Dhaenens (Ghent University)
Waters Corporation
LinkedIn Logo